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Longevity is a complex phenomenon involving multiple environmental and biological factors. Genetic studies of 
longevity have focussed on DNA repair, oxidative damage correction and immune-related genes. Vitamin-D 
works by modulating mineral homeostasis and key physiological processes such as cell proliferation and 
immune response. Vitamin-D insufficiency has been largely considered a risk factor for life-limiting illnesses 
including cardiovascular and immune-related diseases and cancer. Vitamin-D acts through vitamin–D-receptor 
(VDR), which regulates the expression of vitamin-D-response genes. VDR variants have been associated with 
susceptibility to cancer, bacterial and viral infections, autoimmune diseases, and allergies. In the present study 
we evaluated VDR as candidate gene involved in human longevity. We selected five polymorphisms of the VDR 
gene that capture variability at the 5’, coding and 3’ regions. Genotype data was obtained from 104 
octogenarians (>85y) and 114 controls (17-40y). Although differences in genotype and allele distribution did not 
reach statistical significance, haplotype distribution was distinctive, mainly for 3’ region haplotypes and 









Longevity is a complex phenomenon in which environmental, social, stochastic and biological factors are 
involved. Maximum lifespan potential of individuals has a strong biological component; population life 
expectancy is a multifactorial trait based on both biological and non-biological factors. In humans, as in other 
species, long-lived individuals emerge as a result of a successful life, lack of stochastic damaging factors and 
healthy aging. Recent socioeconomic improvements and advances in prevention and treatment of diseases have 
reduced infant mortality as well as allowing individuals to survive to extreme old age. As a result, life 
expectancy in humans has increased in developed countries, with no effect on maximum lifespan potential. 
Social and technological improvements have been crucial to increased human longevity, creating a new scenario 
in which longevity-related biological factors have been able to operate. The aging process has been considered 
the result of the accumulation of damages in cells and tissues that, left uncorrected, produces a systemic 
dysfunction concluding in death. Throughout the lifespan, however, cell maintenance mechanisms, such as 
DNA-repairing enzymes, correction of oxidative damage and immune system response against pathogens and 
tumour cells, attempt to correct the damage.  
Among environmental factors acting on health status, vitamin-D has been largely considered protective and a 
promoter of good health (Holick and Chen 2008). Pleiotropic effects of vitamin-D have been largely known to 
affect mineral metabolism, cell proliferation and immune response modulation. Vitamin-D status has been 
described as involved in life-limiting diseases (Heaney 2008) such as cancer (Garland et al. 2009), 
cardiovascular diseases (Gouni-Berthold et al. 2009), osteoporosis (Lash et al. 2009), sarcopenia (Visser et al. 
2003) and diabetes (Danescu et al. 2009). In addition, vitamin-D has an important role in the modulation of the 
immune response, inducing microbicide factors against bacterial infections (Wang et al. 2004) and controlling 
the exacerbation of the cellular immune response (Deluca and Cantorna 2001). Based on this, it has been 
proposed a major positive role for vitamin-D in biogerontology by reducing susceptibility in the elderly to 
chronic degenerative diseases (Hayes 2010). 
Sources of vitamin-D come from dietary intake, mainly oily fish such as salmon, mackerel and sardines (Chen et 
al. 2007) and egg yolks (Lamberg-Allardt 2006), and from endogenous synthesis by photolytic reaction of 
vitamin-D precursors in the skin (Lips 2006). Both types of sources are strongly linked to environment, such as 
climate and latitude, and social behaviour, such as daily diet, sun exposure and clothing. In addition, 
demographic factors must be considered, such as culture habits, gender and age, which act in several ways to 
change social behaviour as well as race, which is related to melanin pigmentation (Chen et al. 2007). Genes 
coding for vitamin-D metabolic enzymes and downstream mediators of vitamin-D signalling constitute a 
complex gene network. Vitamin-D receptor (VDR) plays a pivotal role in this network, acting as a ligand-
dependent transcription factor that modulates the expression of vitamin-D responsive genes (Pike 1991).  
Several VDR polymorphisms with functional effects have been described in the promoter, coding and 3’ 
untranslated region (UTR) (Uitterlinden et al. 2004a). Two common polymorphisms, Cdx (rs1568820) and 
A1012G (rs4516035), have been located in the 5’ regulatory region that affect binding to transcription factors. 
The rs1568820 polymorphism is a G to A transition between exons 1f and 1e that alters the recognition site for 
the intestinal-specific transcription factor “caudal-related homeodomain protein-2” (Cdx-2), affecting vitamin-D-
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VDR-mediated intestinal calcium absorption (Arai et al. 2001). The rs4516035 polymorphism is an A to G 
transition located between 1e and 1a exons that modifies the GATA-3 transcription factor recognition sequence, 
involved in the regulation of Th2 polarization (Halsall et al. 2004). In addition, a common FokI (rs10735810) 
polymorphism has been described in the VDR coding region that alters the first ATG start site to an alternate 
ACG sequence, giving rise to a VDR protein that is three amino acids shorter (424 aas vs. 427 aas) (Gross et al. 
1996). Functional differences among rs10735810 genotypes shows that VDR protein coded by the C-VDR allele 
(short 424 aas) interacted more efficiently with TFIIB and showed greater transcriptional activity than the full-
length VDR protein coded by T-VDR allele (Jurutka et al. 2000). Finally, a common restriction fragment length 
polymorphism (RFLP), designated as BsmI (rs1544410), and a microsatellite polymorphism, designated as 
PolyA (rs17878969), has been described in the 3’-UTR region (Morrison et al. 1994; Ingles et al. 1997). 
Functional effects of 3’-UTR variants have been related to alterations in VDR mRNA stability (Fang et al. 2005).  
Knowledge of the genomic architecture is important for designing association studies of complex phenotypes, as 
revealed by recent research on the linkage disequilibrium (LD) pattern of the human genome. LD refers to the 
non-random transmission of alleles of neighbouring loci that is high for closer loci and decreases with distance. 
In addition, recombination rate is a determinant factor for decreasing LD. The underlying structure of LD in the 
human genome reveals a series of discrete blocks of high LD interrupted by hotspot recombination sites. LD 
blocks range from 5 to 50 kb and are characterized by a reduced diversity of allelic combinations (haplotypes) 
(Wall and Pritchard 2003). Studies of the VDR genomic region in Caucasians have revealed a scattered LD 
pattern with rs1568820 and rs4516035 polymorphisms included in a single block of the VDR promoter and 
rs1544410 and rs17878969 polymorphisms included in a 3’UTR block. Blocks are separated by a hotspot 
recombination region that includes the rs10735810 polymorphism (Fang et al. 2005).  
Several studies reveal that polymorphisms at VDR locus are associated with life-limiting diseases such as cancer, 
cardiovascular diseases and immune system disturbances (Uitterlinden et al. 2004b). Therefore, we propose VDR 
as a candidate gene involved in human longevity as a result of its protection from age-related diseases and 
modulation of the immune response. Taking advantage of the known haplotype block structure of the VDR 




Material and Methods 
Subjects 
In total, 214 Caucasian subjects from the city of Lleida in northeast Spain were included between January and 
June 2004: 104 octogenarians (>85 years), 72 women (mean age 89.4±3.6; range 85-100) and 32 men (mean age 
89.4±3.2; range 85-97), and 110 sex-matched healthy young individuals, 75 women (mean age 28±5.8; range 17-
39) and 35 men (mean age 29±8.6; range 17-40), were selected as cases and controls, respectively. A 
comprehensive medical history was obtained from each octogenarian, focussing on the absence of vitamin-D 
related illness such as osteoporosis, autoimmune diseases, immunodeficiency and cancer. Written informed 
consent for enrolment in the study and for personal data management was obtained from all subjects in 
accordance with Spanish laws. The Ethics Committee for our institution approved the study. 
DNA sources and Genotyping 
Genomic DNA from controls was extracted from peripheral blood lymphocytes using a KG-Midi extraction kit 
(Camgen, Cambridge, UK). DNA from octogenarians was obtained from buccal swabs using the BuccalAmp 
DNA extraction kit (Epicentre, Madison, USA). VDR genotyping followed protocols described by de la Torre et 
al. (2008). For each subject we obtained genotype information from five polymorphic variants located in the 
VDR gene at: 5’ promoter region, rs11568820 and rs4516035; coding region, rs10735810 and 3’UTR, rs1544410 
and rs17878969 (Fig.1A). All markers were coded as biallelic, including the rs17878969 microsallite 
polymorphism that shows a biphasic distribution of short (<18 adenosine repeats, S) and long (≥18 adenosine 
repeats, L) allele populations (Ingles et al. 1997). 
Statistical analysis 
We compared genotype and allele distribution between controls and octogenarians by contingency table analysis 
performed by the OpenEpi web resource (Sullivan et al. 2009). Fisher exact test P values were considered in 
each comparison. Correction for multiple testing was done applying the SNP spectral decomposition approach, 
which takes into account the linkage disequilibrium between markers (Nyholt 2004). The significance threshold 
required to maintain a Type I error rate of 5% was P=0.036 for two-marker haplotypes and P=0.011 for five-
marker haplotypes. Pair-wise linkage disequilibrium was measured by the normalized D’ coefficient (Lewontin 
1968) that was estimated using Haploview 4.2 software (Barrett et al. 2005). Absolute D’ values range from 0 
(no disequilibrium), indicating that alleles are randomly distributed and all expected haplotypes are observed, to 
1 (complete disequilibrium), indicating a non random distribution of alleles with a less observed haplotypes than 
expected. 
We used PHASE 2.1.1 software (Stephens et al. 2001) to perform statistical inference of haplotypes from our 
sample data. Only data from fully genotyped subjects, 86 octogenarians (25 males) and 101 controls (35 males), 
were considered. We used the “out_pair” PHASE output file to assign haplotypes for each individual, with their 
corresponding probability. Haplotype counts were estimated by obtaining the cumulative probability of each 
haplotype. In brief, for an individual bearing haplotype A with probability 0.3 and haplotype B with probability 
0.7, 0.3 and 0.7 were added to the corresponding counts of haplotypes A and B, respectively. Following the 
same rationale, we estimated the presence of 0, 1 or 2 copies of a specific haplotype in each individual. 
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Comparison of global haplotype distribution between controls and octogenarians was done by the “product of 
approximate conditionals” (PAC)-likelihood test implemented in PHASE 2.1.1 (Li and Stevens 2003). 
Differences between groups for specific haplotypes were evaluated by 2x2 contingency table analysis performed 




The genotype and allele distribution conform to Hardy-Weinberg equilibrium for all markers in both the control 
and octogenarian samples. We evaluated differences in genotype and allele distribution between octogenarians 
and controls, considering all subjects, gender between groups and gender within each group (Table 1). No 
statistical differences were observed for single-marker genotype association modelled as dominant (common 
allele homozygotes and heterozygotes vs. rare allele homozygotes), recessive (rare allele homozygotes vs. 
common allele homozygotes and heterozygotes) and codominant (cross genotype comparison). Allele 
distribution did not differ in any comparison performed (Table 1). 
Linkage disequilibrium pattern in the control sample was in accordance with available data for Caucasian 
populations (Fang et al. 2005) and block structure (D’>0.8) was observed for markers rs11568820-rs4516035 
(block-1, Fig.1B) and markers rs1544410-rs17878969 (block-2, Fig.1B). Exon-2 polymorphism (rs10735810) 
did not show any significant D’ with the 5’ or 3’UTR markers. In contrast, a modest D’ value (D’<0.68) was 
observed in the octogenarian sample (Fig.1B). 
According to the observed LD pattern, haplotypes were independently inferred from 5’ and 3’UTR markers 
(block 1 and 2, respectively). No statistical differences were observed for 5’UTR haplotype distribution 
(rs11568820 and rs4516035, block 1) between controls and octogenarians. However, statistically significant 
differences were observed for global 3’UTR haplotype distribution (rs1544410 and rs17878969, block 2) 
between controls and octogenarians (PHASE PAC-likelihood test P=0.01) (Fig.2A), mainly due to differences in 
male subjects (PHASE PAC-likelihood test P=0.01) (Fig.2B). Haplotype-specific test revealed that rs1544410-
G:rs17878969-S (GS) haplotype was overrepresented in octogenarians (7.3% vs. 0.8%; odds ratio (OR): 15.3, 
95% confidence interval (CI): 2.3-637; P<0.001) (Fig.2A). This difference was greater in males (14.2% in 
octogenarians vs. 0.3% in controls, OR out of range, P=0.006) (Fig.2B). We also estimated the haplotype carrier 
status of each individual. The distribution of carriers of at least one copy of 3’UTR GS haplotype is presented in 
Table 2. Carriers of at least one copy of GS haplotype were common in octogenarians (13.3%) but rare in 
controls (1.6%) (P=0.008). Among males, nearly a quarter of the octogenarians carried at least one copy of GS 
haplotype, whereas GS carriers represent less than 1% of controls (24.4% vs. 0.7%, respectively; P=0.013). 
Extended five-marker haplotypes were also estimated. Prevalence in controls and octogenarians is presented in 
Fig.3. Extended five-marker haplotype counts and frequencies were compared between groups. Global five-
marker haplotype distribution showed statistically significant differences (PHASE PAC-likelihood test P=0.020) 
(Fig.3A), again mainly contributed by differences in males (PHASE PAC-likelihood test P=0.020) (Fig.3B). 
Five-marker haplotype-specific test revealed that rs11568820-G:rs4516035-G:rs10735810-C:rs1544410-
G:rs17878969-S (GGCGS) haplotype was differentially distributed between groups (0.25% in controls vs. 4.1% 
in octogenarians, OR: 11.5; 95%CI: 1.2-621, P=0.024; Fig.3A). Again, these differences were mainly due to 
males (0.07% in controls vs. 9.5% in octogenarians, OR out of range; P=0.014; Fig.3B). The distribution of 
carriers of at least one copy of GGCGS haplotype (0.5% in controls and 8.3% in octogenarians, P=0.023) is 
presented in Table 2. Males carrying at least one copy of GGCGS haplotype represent just 0.1% in controls but 




Long-lived people escaped or delayed major age-related illnesses such as cardiovascular diseases and cancer, as 
well as life-threatening infections and immune-related diseases. It is noteworthy that vitamin-D plays a key role 
in these impairing diseases (Holick 2005). A general concern exists about the vitamin-D insufficiency that has 
been found in older persons (Holick 2006). Recent data indicates that low serum levels of 25-hydroxyvitamin-D 
are associated with all-cause mortality in the general population (Dobnig et al. 2008) as well as in older men and 
women (Pilz et al. 2009). However, the question of whether vitamin-D deficiency is a cause or a consequence of 
poor health status remains to be answered.  
Additional evidence supports a role for vitamin-D in the aging process (Lanske and Razzaque 2007; Tuohimaa 
2009). Studies in animal models have revealed a paradoxical effect of vitamin-D on aging. Genetically modified 
mice lacking FGF23 and Klotho genes exhibit features of premature aging that have been related with an altered 
mineral homeostasis and hypervitaminosis-D due to increased 1-α-hydroxilase activity (Razzaque and Lanske 
2006). At the same time, null mice for the vitamin-D receptor gene, in which vitamin-D action cannot occur, also 
show features related with premature aging (Keisala et al. 2009). According to this, it has been proposed that 
aging shows a hormetic U-shaped dependency on hormonal forms of vitamin-D where both hyper- and 
hypovitaminosis are risk factors for abnormal aging (Tuohimaa 2009). This bimodal effect of vitamin-D levels 
also has been described for vascular disease risk in children on dialysis (Shroff et al. 2008) and prostate cancer 
risk in Nordic countries (Tuohimaa et al. 2004). Therefore, it can be assumed that for good health status there is 
a narrow range for optimal serum concentration of vitamin-D forms. 
VDR acts as a nuclear receptor for vitamin-D and is responsible for its genomic action. Several VDR gene 
polymorphic variants have been described as affecting VDR gene expression (rs11568820 and rs4516035), 
protein structure (rs10735810) and mRNA stability (rs1544410 and rs17878969) (Fang et al. 2005; Uitterlinden 
et al. 2004a). Variability at the VDR locus has been associated with cancer, osteoporosis, cardiovascular diseases 
and diabetes (Uitterlinden et al. 2004b) as well as mycobacterium (Bellamy and Hill 1998) and viral infections 
(Fibla and Caruz 2010). 
While the vitamin-D effect on impairing diseases and aging has been well studied, the effect of VDR variability 
has been evaluated only in relation to diseases; no data exist about its role in aging and longevity. In the present 
case-control study, we compared allele, genotype and haplotype distribution of five VDR gene variants between 
healthy-living octogenarians and younger controls to assess VDR as a candidate gene affecting aging and 
longevity. Our study is the first to provide evidence of an association between VDR gene polymorphisms and 
longevity, as reflected by the differential distribution of VDR haplotypes that we observed. The positive 
significant association between longevity and the 3’UTR GS and five-marker GGCGS haplotypes was observed 
in octogenarian males but not in women. Epidemiological data on long-lived subjects document a clear-cut 
prevalence of females compared to males, suggesting that sex-specific mortality rates follow different 
trajectories. Demographic and behavioural risk factors have been considered in the literature, but do not account 
for the overall sex-related difference in mortality rates (Wingard 1984). In addition, the role of biological factors 
has been explored with contentious results (Austad 2006). Our finding of a sex-specific association was in 
accordance with previous reports that certain polymorphisms of the interleukin (IL)-6, IL-10 and interferon-
gamma genes are male-specific markers for longevity (Bonafe et al. 2001; Di Bona et al. 2009; Giacconi et al. 
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2004; Lio et al. 2002a; Lio et al. 2002b), supporting a finding that female longevity is less dependent on genetic 
background than male longevity (Franceschi et al. 2000).  
With respect to the biogerontological significance of the observed association, we can only suggest a reasonable 
potential explanation. From functional studies, the common 3’UTR haplotypes GL and AS have been linked to 
low and high mRNA stability, respectively (Fang et al. 2005). However, no causative effect has been assigned to 
rs1544410 or rs17878969 polymorphisms. The main resulting hypothesis is to consider those polymorphisms as 
markers for an unknown causative element located in the 3’UTR region  In octogenarians, we found an increase 
of the GS haplotype prevalence. GS haplotype combines elements of the two common GL and AS haplotypes, 
from which we can expect an intermediate phenotype. Assuming the vitamin-D effect on the aging process 
follows a hormetic U-shaped model (Tuohimaa 2009), haplotypes conferring low (GL) and high (AS) VDR 
mRNA stability contributes to an adverse Vitamin-D response caused by deficiency and toxicity, respectively. 
However, haplotypes conferring a middle VDR mRNA stability (i.e. GS) can be considered as protective, as 
Vitamin-D response can remain in the homeostatic region, producing neither deficiency nor toxicity.  
No previous study has been specifically designed to evaluate differences in VDR variants between young and 
elderly subjects. The literature contains indirect data on genotype frequencies of VDR markers, but comparison 
with our data is inappropriate due to differences in the origin of each population and in selection criteria. We 
acknowledge that our study has a number of potential limitations. Although octogenarian Caucasian cohorts may 
have common characteristics, such as the limited medical care available until the 1950s, we cannot exclude 
potential confounding factors. In particular, two historical events must be taken into account: the Spanish flu 
epidemic at the beginning of the 20th century, which depleted the childhood population, and the Civil War 
(1936-1939) that had an especially important impact on male mortality (González et al. 1996). The first event 
could have produced biological consequences, while the second had a stochastic effect. Another concern refers 
to the comparison of different birth cohorts, within which we assumed that initial frequencies are similar (Capri 
et al 2008). We cannot exclude this confounding factor in our study. However, our cohorts fit Hardy Weinberg 
equilibrium in all loci analyzed, and neither disturbances on random matting nor selective factors attributable to 
the VDR locus can be expected to act before reproductive age. Therefore, we could hypothesize that genotype 
and allelic frequencies are maintained over generations. 
In conclusion, the well-documented impact of vitamin-D levels on the aging process and on age-related diseases 
is bolstered by our results. In addition, the study results propose a new scenario in which the variability of the 
VDR gene is also relevant and emphasize the role of VDR genetic background in determining optimal vitamin-D 
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Figure 1.- Gene structure of the VDR locus and linkage disequilibrium (LD) pattern of populations analysed. (A) 
Graphical representation of the VDR gene with the location of polymorphisms selected. Polymorphisms are 
named according to rs code and alias. Small open arrows indicate alternative VDR promoters that incorporate 
alternative exon 1 (1a-1f). Grey boxes correspond to untranslated exons, empty boxes to coding exons. UTR, 
untranslated region. All markers were coded as biallelic including the rs17878969 microsallite polymorphism 
that shows a biphasic distribution of short (<18 adenosine repeats, S) and long (≥18 adenosine repeats, L) allele 
populations (Ingles et al. 1997). (B) Graphical representation of the LD pattern in Controls and Octogenarians. 
D’ values were calculated and plotted by Haploview 4.2 software (http://www.broad.mit.edu/mpg/haploview). 
Numbers inside boxes correspond to D’ x100. Block structure was considered for marker pairs showing D’>0.8, 
following the “solid-spine” block definition implemented in Haploview.  In controls, two blocks were identified, 
block-1 at the 5’ regulatory region including markers rs4516035-rs11568820 and block-2 at the 3’UTR region 
including markers rs17878969-rs1544410. No block pattern was observed in octogenarians. 
 
Figure 2.- 3’UTR haplotype prevalence in controls (CTR) and octogenarians (OCT). Histograms plot of the 
3’UTR haplotype prevalence in all subjects (A) and in males (B). Bars indicate 95% confidence interval of the 
proportion. Global distribution of haplotypes was compared by the PAC-likelihood test implemented in PHASE 
2.1.1 (Li and Stevens 2003). Haplotype-specific test was performed by 2x2 contingency table analysis. 
Experiment-wide significance threshold required to keep Type I error rate at 5% was P=0.036. 
 
Figure 3.- Five-marker haplotype prevalence in controls (CTR) and octogenarians (OCT). Histogram plot of 
five-marker haplotype prevalence in all subjects (A) and in males (B). Bars indicate 95% confidence interval of 
the proportion. Global distribution of haplotypes was compared by the PAC-likelihood test implemented in 
PHASE 2.1.1 (Li and Stevens 2003). Haplotype-specific test was performed by 2x2 contingency table analysis. 
Experiment-wide significance threshold required to keep Type I error rate at 5% was P=0.011. 
 




   Controls  Octogenarians  
 
Genotypes.  
alleles   
 

















               
rs11568820   GG   61 (59.2)   21 (60)   40 (58.8)   63 (69.2)   18 (69.2)   45 (69.2) 
 Cdx   GA   38 (36.9)   12 (34.3)   26 (38.2)   25 (27.5)   6 (23.1)   19 (29.3) 
    AA   4 (3.9)   2 (5.7)   2 (3)   3 (3.3)   2 (7.7)   1 (1.5) 
    G   160 (77.7)   54 (77.1)   54 (77.1)   151 (83)   42 (80.8)   109 (83.8) 
    A   46 (22.3)   16 (22.9)   16 (22.9)   31 (17.0)   10 (19.2)   21 (16.2) 
Genotype failure 
a 
  7 (6.4)   0 (0)   7(9.3)   13 (12.5)   6 (18.8)   7 (9.7) 
               
 rs4516035  GG  41 (37.6)  14 (40)  27 (36.5)  29 (29.3)  9 (30)  20 (29) 
 A1012G  GA  56 (51.4)  18 (51.4)  38 (51.4)  55 (55.5)  15 (50)  40 (58) 
  AA  12 (11)  3 (8.6)  9 (12.1)  15 (15.2)  6 (20)  9 (13) 
  A  138 (63.3)  46 (65.7)  46 (65.7)  113 (57.1)  33 (55)  80 (58) 
  G  80 (36.7)  24 (34.3)  24 (34.3)  85 (42.9)  27 (45)  58 (42) 
Genotype failure  1 (0.9)  0 (0)  1 (1.3)  5 (4.8)  3 (9.4)  2 (2.8) 
               
rs2228570   CC   43 (39.1)   13 (37.1)   30 (40)   46 (46.5)   15 (46.9)   31 (46.3) 
 FokI   CT   58 (52.7)   18 (51.4)   40 (53.3)   39 (39.4)   10 (31.2)   29 (43.3) 
    TT   9 (8.2)   4 (11.5)   5 (6.7)   14 (14.1)   7 (21.9)   7 (10.4) 
    C   144 (65.5)   44 (62.9)   44 (62.9)   131 (66.2)   40 (62.5)   91 (67.9) 
    T   76 (34.5)   26 (37.1)   26 (37.1)   67 (33.8)   24 (37.5)   43 (32.1) 
Genotype failure   0 (0)   0( 0)   0 (0)   5 (4.8)   0 (0)   5 (6.9) 
               
 rs1544410  GG  37 (33.6)  10 (28.6)  27 (36)  30 (29.2)  10 (31.2)  20 (28.2) 
 BsmI  GA  50 (45.5)  17 (48.5)  33 (44)  56 (54.3)  20 (62.5)  36 (50.7) 
  AA  23 (20.9)  8 (22.9)  15 (20)  17 (16.5)  2 (6.3)  15 (21.1) 
  G  124 (56.4)  37 (52.9)  37 (52.9)  116 (56.3)  40 (62.5)  76 (53.5) 
  A  96 (43.6)  33 (47.1)  33 (47.1)  90 (43.7)  24 (37.5)  66 (46.5) 
Genotype failure  0(0)  0(0)  0(0)  1(1.0)  0(0)  1(1.4) 
               
 rs17878969   LL   43 (39.8)   10 (28.6)   33 (45.2)   36 (35.3)   11 (34.4)   25 (35.7) 
 PolyA   LS   48 (44.5)   17 (48.6)   31 (42.5)   44 (43.1)   12 (37.5)   32 (45.7) 
    SS   17 (15.7)   8 (22.8)   9 (12.3)   22 (21.6)   9 (28.1)   13 (18.6) 
    L   134 (62)   37 (52.9)   37 (52.9)   116 (56.9)   34 (53.1)   82 (58.6) 
    S   82 (38)   33 (47.1)   33 (47.1)   88 (43.1)   30 (46.9)   58 (41.4) 
Genotype failure   2 (1.8)   0 (0)   2 (2.7)   2 (1.9)   0 (0)   2 (2.8) 
               
Global Genotype failure  10 (1.8)  0 (0)  10 (2.6)  26 (5.0)  9 (5.6)  17 (4.7) 
                              
 
a) Number of subjects with missing genotypes
 
table
Click here to download table: BGEN-10-14_Revised_TABLES-1&2.doc
 
 









































d  0.5 (0.5)  0.05 (0.1)  0.45 (0.7)  7.1 (8.3)  4.7 (18.9)  2.4 (3.9) 
 
a) Carriers were those bearing one or two copies of the corresponding haplotype 
b) Counts refer to the number of haplotype carriers that were statistically inferred from PHASE 2.1.1 “out_pairs” output file 
c) Haplotype rs1544410-G:rs17878969-S. Fisher exact test, octogenarians vs. controls: all subjects, odds ratio (OR): 7.1; 95% confidence interval 
(CI): 1.5-66.3, P=0.008; males, OR out of range, P=0.013. Experiment-wide significance threshold required to keep Type I error rate at 5% was 
P=0.036.  
d) Haplotype rs11568820-G:rs4516035-G:rs10735810-C:rs1544410-G:rs17878969-S. Fisher exact test, octogenarians vs. controls: all subjects, OR: 
11.9; 95%CI: 1.3-650, P=0.023; males, OR out of range, P=0.012. Experiment-wide significance threshold required to keep Type I error rate at 5% 
was P=0.011. 
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